Insider · CIK 0001795902

van Es-Johansson An

Reports to the SEC for 3 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001795902

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+921 sh	—	—	1,843
2026-10-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−921 sh	—	—	1,843
2026-07-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+922 sh	—	—	922
2026-07-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−922 sh	—	—	2,764
2026-05-14	CNSYCERENOME, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,686 sh	—	—	3,686
2026-05-14	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,686 sh	—	—	3,686
2025-12-09	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	102,500
2025-08-13	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+298K sh	—	—	297,794
2025-02-18	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.1K sh	—	—	40,122
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−1,100 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,345 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,328 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,431 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,910 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,729 sh	—	—	0
2024-12-12	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	62,500
2024-09-11	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,650 sh	—	—	3,650
2024-06-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,328 sh	—	—	3,328
2024-02-22	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,250 sh	—	—	2,250
2023-12-14	SVRASavara IncA Award	Director	AAward	+22.5K sh	—	—	22,500
2023-05-10	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,345 sh	—	—	3,345
2023-02-15	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,182
2022-12-13	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-05-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,431 sh	—	—	3,431
2021-12-14	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-05-25	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,336 sh	—	—	6,336
2021-05-20	LUMOS PHARMA, INC.A Award	Director	AAward	+367 sh	—	—	1,100
2021-05-20	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+2,910 sh	—	—	2,910
2020-12-16	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-25	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2020-01-09	CNSYCERENOME, INC. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-12-20	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000

Recent filings

Accepted (ET)
Oct 14
van Es-Johansson An0001193125-26-409859
SEC(opens sec.gov)
Jul 14
van Es-Johansson An0001193125-26-292643
SEC(opens sec.gov)
May 184
van Es-Johansson An0001193125-26-228933
SEC(opens sec.gov)
Dec 114
van Es-Johansson An0001193125-25-316307
SEC(opens sec.gov)
Aug 154
van Es-Johansson An0000950170-25-109408
SEC(opens sec.gov)
Feb 204
van Es-Johansson An0000950170-25-024341
SEC(opens sec.gov)
Dec 164
van Es-Johansson An0000950170-24-136773
SEC(opens sec.gov)
Dec 134
van Es-Johansson An0001126234-24-000118
SEC(opens sec.gov)
Sep 124
van Es-Johansson An0000950170-24-105960
SEC(opens sec.gov)
Jun 74
van Es-Johansson An0001126234-24-000078
SEC(opens sec.gov)
Feb 264
van Es-Johansson An0000950170-24-020414
SEC(opens sec.gov)
Dec 154
van Es-Johansson An0001209191-23-058846
SEC(opens sec.gov)

Companies

Address

C/O PLUS THERAPEUTICS INC. 6420 LEVIT GREEN BOULEVARD, SUITE 310

HOUSTON, TX, 77021